The loss of Myriad Genetics under GAAP for the nine months of 2021 was $19.6 million, down 9.3 times from $185.9 million in the previous year. Revenues increased 31.7% to $529.8 million from $402.4 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept